MD Anderson Cancer Center
Facts about myelodysplastic syndrome - CNL
Around 15,000 people in the United States are diagnosed each year with myelodysplastic syndrome (MDS).  MDS occurs when the bone marrow does not properly produce one or more of the following: red blood cells, white blood cells and/or platelets. In the past it was thought MDS was only deadly when it developed into acute myelogenous leukemia (AML), but current research shows MDS can be fatal without reaching the stage of AML. Guillermo Garcia-Manero, M.D., professor in Leukemia, explains the basics, diagnosis, treatment and new therapies for myelodysplastic syndrome. MDS is part of MD Anderson’s Moon Shots Program; is a highly-concentrated effort to rapidly and dramatically decrease suffering and death in several major cancers.

Transcript Transcript     Accessibility shortcut keys (H) Shortcuts
Loading the Audio Player...

Title: Facts about myelodysplastic syndrome - CNL
Summary: Around 15,000 people in the United States are diagnosed each year with myelodysplastic syndrome (MDS).  MDS occurs when the bone marrow does not properly produce one or more of the following: red blood cells, white blood cells and/or platelets. In the past it was thought MDS was only deadly when it developed into acute myelogenous leukemia (AML), but current research shows MDS can be fatal without reaching the stage of AML. Guillermo Garcia-Manero, M.D., professor in Leukemia, explains the basics, diagnosis, treatment and new therapies for myelodysplastic syndrome. MDS is part of MD Anderson’s Moon Shots Program; is a highly-concentrated effort to rapidly and dramatically decrease suffering and death in several major cancers.
Keywords: myelodysplastic syndrome, mds, leukemia, aplastic anemia, Garcia-Manero, blood, bone marrow, cnl, cancer newsline
Transcript: http://www.mdanderson.org/transcripts/cancer-newsline/2012/cnl-mds.html